Long-term efficacy of abrocitinib in adolescents and adults with moderate-to-severe atopic dermatitis: a post hoc analysis of JADE EXTEND

被引：1
|
作者：
Paller, Amy S. [1 ]
Cork, Michael J. [2 ]
Flohr, Carsten [3 ]
Bangert, Christine [4 ]
Weidinger, Stephan [5 ]
Nesnas, John [6 ]
Farooqui, Saleem A. [7 ]
Biswas, Pinaki [8 ]
Watkins, Melissa [8 ]
Koppensteiner, Herwig [9 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL USA
[2] Univ Sheffield & Sheffield Childrens Hosp, Sheffield Dermatol Res, IICD, Sheffield, England
[3] Kings Coll London, St Johns Inst Dermatol, Guys & St Thomas NHS Fdn Trust, London, England
[4] Med Univ Vienna, Vienna, Austria
[5] Univ Hosp Schleswig Holstein, Kiel, Germany
[6] Pfizer Ltd, Tadworth, England
[7] Pfizer R UK Ltd, Tadworth, England
[8] Pfizer Inc, New York, NY USA
[9] Pfizer Corp Austria GmbH, Vienna, Austria
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷
关键词：
D O I：
10.1093/bjd/ljad113.109
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P81
引用
收藏
页数：2
相关论文
共 50 条
  • [1] EFFICACY AND SAFETY OF ABROCITINIB MONOTHERAPY IN ADULTS AND ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS: A POST HOC ANALYSIS OF JADE REGIMEN
    Flohr, Carsten
    Cork, Michael J.
    Eichenfield, Lawrence F.
    Feeney, Claire
    Koppersteiner, Herwig
    Lazariciu, Irina
    Nesnas, John
    [J]. ACTA DERMATO-VENEREOLOGICA, 2022, 102 : 31 - 31
  • [2] Long-term efficacy of abrocitinib up to 96 weeks in adults with moderate-to-severe atopic dermatitis stratified by age: a post hoc analysis of the JADE EXTEND phase 3 trial
    Alexis, Andrew F.
    Deleuran, Mette
    Silverberg, Jonathan, I
    Gooderham, Melinda J.
    Farooqui, Saleem A.
    Chan, Gary
    Koppensteiner, Herwig
    Biswas, Pinaki
    Watkins, Melissa
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 188
  • [3] Long-term management of moderate-to-severe atopic dermatitis with abrocitinib: a phase III extension study (JADE EXTEND)
    Reich, K.
    Silverberg, J. I.
    Papp, K.
    Deleuran, M.
    Katoh, N.
    Strober, B.
    Beck, L. A.
    de Bruin-Weller, M.
    Werfel, T.
    Zhang, F.
    Biswas, P.
    DiBonaventura, M.
    Chan, G. L.
    Farooqui, S. A.
    Kerkmann, U.
    Clibborn, C.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (03) : E141 - E142
  • [4] Protocol for an ongoing, phase III multicentre, long-term extension study investigating the long-term safety and efficacy of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE EXTEND)
    Simpson, E. L.
    Reich, K.
    Silverberg, J. I.
    Nasir, A.
    Criado, P. R.
    Biswas, P.
    Koppensteiner, H.
    Fan, D.
    Rojo, R.
    Farooqui, S. A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2022, 186 (04) : E159 - E159
  • [5] Abrocitinib Long-Term Efficacy for up to 96 Weeks in Patients With Moderate-to-Severe Atopic Dermatitis: Interim Analysis of JADE EXTEND, a Long-Term Extension Study
    Reich, Kristian
    Silverberg, Jonathan I.
    de Bruin-Weller, Marjolein
    Deleuran, Mette
    Beck, Lisa A.
    Papp, Kim
    Farooqui, Saleem A.
    Zhang, Fan
    Feeney, Claire
    Koppensteiner, Herwig
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB116 - AB116
  • [6] Phase 3 efficacy and safety of abrocitinib in adults with moderate-to-severe atopic dermatitis after switching from dupilumab (JADE EXTEND)
    Shi, Vivian Y.
    Bhutani, Tina
    Fonacier, Luz
    Deleuran, Mette
    Shumack, Stephen
    Valdez, Hernan
    Zhang, Fan
    Chan, Gary L.
    Cameron, Michael C.
    Yin, Natalie C.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (02) : 351 - 358
  • [7] Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis
    Li, Ling
    Yu, Jiajun
    Chen, Baoqing
    Guo, Ying
    Yang, Yufeng
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [8] Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: A post hoc analysis of the JADE REGIMEN phase 3 trial
    Li, Hang
    Cheng, Hao
    Lu, Qianjin
    Lai, Wei
    Tao, Xiaohua
    Encinas, Gerardo A.
    Vyas, Shefali
    Wang, Bo
    Luo, Xin
    Li, Shiqi
    [J]. CHINESE MEDICAL JOURNAL, 2024, 137 (16) : 1991 - 1992
  • [9] Efficacy and safety of abrocitinib in Chinese patients with moderate-to-severe atopic dermatitis: A post hoc analysis of the JADE REGIMEN phase 3 trial
    Li Hang
    Cheng Hao
    Lu Qianjin
    Lai Wei
    Tao Xiaohua
    Encinas Gerardo A
    Vyas Shefali
    Wang Bo
    Luo Xin
    Li Shiqi
    [J]. 中华医学杂志英文版., 2024, 137 (16)
  • [10] LONG-TERM EFFICACY OF TRALOKINUMAB IN ADOLESCENTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Wollenberg, Andreas
    Paller, Amy S.
    Bewley, Anthony
    Cork, Michael
    Hong, Chih-Ho
    Soong, Weily
    Oland, Christian Bjerregard
    Taveira, Christian Moreira
    Gjerum, Le
    Blauvelt, Andrew
    [J]. ACTA DERMATO-VENEREOLOGICA, 2023, 103 : 54 - 54
12345